The Trillium Extracellular Vesicles 2023 issue was published in September 2023
You may download your personal copy HERE
The call for our TEV 2024 issue will be opened in February 2024. If you are interested in submitting a manuscript to our next issue please send a tentative title and short abstract (100-200 words) to the Editor-in-Chief directly.
The peer-reviewed proceedings of the German Society for Extracellular Vesicles (GSEV)
Aim and Scope
Trillium Extracellular Vesicles publishes high-quality research and review articles in the broad field of extracellular vesicles. This includes all aspects of extracellular vesicle biology, such as their role in cancer infection, inflammation and other dispositions; extracellular vesicles in physiological homeostasis; extracellular vesicle isolation and characterisation, including technical and methodological papers; extracellular vesicles from mammalian and non-mammalian sources, such as bacteria, fungi, and plants; extracellular vesicles for therapeutic applications, including drug delivery applications; extracellular vesicles in regenerative medicine, and clinical evaluations of extracellular vesicles.
Submitted manuscripts will undergo a scientific quality and suitability check by the editorial team. The handling editor decides which articles are sent out for peer-review. At least two independent reviewers who submit their comments to the editor and the authors will assess each manuscript. Authors will be given the opportunity to revise their papers and the editor will decide on the suitability to publish.
Benefits to authors
Publications in TEV are at no charge for authors. We also provide other benefits, such as free PDFs, a liberal copyright policy, free print copies of TEV and much more.
Please see our Author guidelines below for information on article types and submission.
Trillium Extracellular Vesicles is published once a year, both in print and online.
If you are interested in publishing with us, contact the Editor-in-Chief (Dr Gregor Fuhrmann) directly.
TEV 2020 issue focusses on EVs as diagnostic and other markers - even during home office hours!
The entire issue can be seen here click here.